Goodrx Holdings Inc (GDRX)

NASDAQ
Currency in USD
4.49
+0.04(+0.90%)
Closed·
After Hours
4.490.00(0.00%)
·
GDRX Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
4.394.49
52 wk Range
3.829.26
Key Statistics
Edit
Prev. Close
4.45
Open
4.45
Day's Range
4.39-4.49
52 wk Range
3.82-9.26
Volume
545.79K
Average Vol. (3m)
1.45M
1-Year Change
-32.88%
Book Value / Share
1.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GDRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.63
Upside
+47.55%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Goodrx Holdings Inc Company Profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Employees
738

Goodrx Holdings Inc SWOT Analysis


Market Dynamics
Learn how GoodRx navigates competitive pressures and pharmacy closures while analysts set price targets ranging from $4.25 to $10
Growth Strategies
Delve into GoodRx's focus on Pharma Manufacturer Solutions and Integrated Savings Program as key drivers for future expansion
Financial Resilience
Explore GoodRx's robust financials, including high gross profit margins and strong free cash flow yield, despite industry headwinds
Digital Health Pionee
GoodRx leads in prescription savings, leveraging its platform to make healthcare more affordable amid evolving pharmacy landscape challenges
Read full SWOT analysis

Goodrx Holdings Inc Earnings Call Summary for Q4/2024

  • Q4 2024 EPS of $0.09 missed $0.10 forecast; revenue at $198.6M slightly below expectations; stock rose 1.23% pre-market
  • Full-year 2024 revenue up 6% to $792.3M; net income positive at $16.4M, reversing 2023 loss; gross profit margins at 94.09%
  • 2025 guidance: revenue $810M-$840M (4% growth); adjusted EBITDA $270M-$286M (7% growth); focus on expanding partnerships
  • Strategic initiatives include brand partnerships, new product launches; company maintains strong liquidity with 5.48 current ratio
  • Challenges: pharmacy closures, GLP-1 medication pricing, market saturation; CEO emphasizes mission to save on medications
Last Updated: 02/27/2025, 09:17 AM
Read Full Transcript

Compare GDRX to Peers and Sector

Metrics to compare
GDRX
Peers
Sector
Relationship
P/E Ratio
105.1x−1.4x−0.5x
PEG Ratio
0.370.000.00
Price / Book
2.4x0.9x2.6x
Price / LTM Sales
2.2x1.5x2.9x
Upside (Analyst Target)
33.6%50.4%66.3%
Fair Value Upside
Unlock16.4%10.2%Unlock

Analyst Ratings

8 Buy
7 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.63
(+47.55% Upside)

Earnings

Latest Release
Feb 27, 2025
EPS / Forecast
0.09 / 0.10
Revenue / Forecast
198.60M / 199.76M
EPS Revisions
Last 90 days

People Also Watch

41.18
HOOD
+1.28%
58.08
NVO
-7.63%
51.70
MRVL
-0.44%
84.80
DELL
+1.73%
78.00
MRK
+2.01%

FAQ

What Is the Goodrx (GDRX) Stock Price Today?

The Goodrx stock price today is 4.49

What Stock Exchange Does Goodrx Trade On?

Goodrx is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Goodrx?

The stock symbol for Goodrx is "GDRX."

What Is the Goodrx Market Cap?

As of today, Goodrx market cap is 1.72B.

What is Goodrx Earnings Per Share?

The Goodrx EPS is 0.04.

What Is the Next Goodrx Earnings Date?

Goodrx will release its next earnings report on May 07, 2025.

From a Technical Analysis Perspective, Is GDRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.